Vanguard Group
GTHX

Vanguard Group’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,491,109
Closed -$5.68M 4396
2024
Q2
$5.68M Buy
2,491,109
+409,536
+20% +$934K ﹤0.01% 3204
2024
Q1
$8.99M Buy
2,081,573
+99,900
+5% +$432K ﹤0.01% 3021
2023
Q4
$6.04M Buy
1,981,673
+31,605
+2% +$96.4K ﹤0.01% 3207
2023
Q3
$2.81M Hold
1,950,068
﹤0.01% 3477
2023
Q2
$4.86M Sell
1,950,068
-40,707
-2% -$101K ﹤0.01% 3316
2023
Q1
$5.34M Buy
1,990,775
+64,930
+3% +$174K ﹤0.01% 3279
2022
Q4
$10.5M Buy
1,925,845
+239,392
+14% +$1.3M ﹤0.01% 2930
2022
Q3
$21.1M Buy
1,686,453
+65,952
+4% +$824K ﹤0.01% 2598
2022
Q2
$8.01M Sell
1,620,501
-303,203
-16% -$1.5M ﹤0.01% 3106
2022
Q1
$14.6M Sell
1,923,704
-620,661
-24% -$4.72M ﹤0.01% 2948
2021
Q4
$26M Buy
2,544,365
+38,297
+2% +$391K ﹤0.01% 2699
2021
Q3
$33.6M Buy
2,506,068
+3,242
+0.1% +$43.5K ﹤0.01% 2580
2021
Q2
$54.9M Buy
2,502,826
+61,841
+3% +$1.36M ﹤0.01% 2318
2021
Q1
$58.7M Buy
2,440,985
+345,258
+16% +$8.31M ﹤0.01% 2230
2020
Q4
$37.7M Buy
2,095,727
+76,307
+4% +$1.37M ﹤0.01% 2345
2020
Q3
$23.3M Sell
2,019,420
-37,791
-2% -$436K ﹤0.01% 2386
2020
Q2
$49.9M Buy
2,057,211
+8,124
+0.4% +$197K ﹤0.01% 2015
2020
Q1
$22.6M Buy
2,049,087
+35,522
+2% +$391K ﹤0.01% 2229
2019
Q4
$53.2M Buy
2,013,565
+21,222
+1% +$561K ﹤0.01% 2082
2019
Q3
$45.4M Buy
1,992,343
+15,728
+0.8% +$358K ﹤0.01% 2116
2019
Q2
$60.6M Buy
1,976,615
+100,523
+5% +$3.08M ﹤0.01% 1998
2019
Q1
$31.1M Buy
1,876,092
+176,440
+10% +$2.93M ﹤0.01% 2304
2018
Q4
$32.5M Sell
1,699,652
-18,081
-1% -$346K ﹤0.01% 2232
2018
Q3
$89.8M Buy
1,717,733
+743,596
+76% +$38.9M ﹤0.01% 1865
2018
Q2
$42.3M Sell
974,137
-30,694
-3% -$1.33M ﹤0.01% 2209
2018
Q1
$37.2M Buy
1,004,831
+236,363
+31% +$8.76M ﹤0.01% 2219
2017
Q4
$15.2M Buy
768,468
+528,757
+221% +$10.5M ﹤0.01% 2615
2017
Q3
$5.97M Buy
239,711
+165,711
+224% +$4.12M ﹤0.01% 3046
2017
Q2
$1.29M Buy
+74,000
New +$1.29M ﹤0.01% 3514